Ovid Therapeutics Inc.
OVID· Nasdaq
Released May 7, 2019, before the open
10-Q filed May 7, 2019, 37 days after period end · 0001564590-19-016562
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$13.80M | -$13.18M | -$34.24M | -$3.68M |
| EPS Diluted | -$0.46 | -$0.54 | -$3.48 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR